No.	Year	Title	Author	Corresponding	Journal	Vol.	Pages
1	2020	Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor.	Okuyama T, Shirakawa J, Tajima K, Ino Y, Vethe H, Togashi Y, Kyohara M, Inoue R, Miyashita D, Li J, Goto N, Ichikawa T, Yamasaki S, Ohnuma H, Takayanagi R, Kimura Y, Hirano H, Terauchi Y.	Shirakawa J	Int J Mol Sci.	21	7815
2	2020	Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects.	Kyohara M, Shirakawa J, Okuyama T, Togashi Y, Inoue R, Li J, Miyashita D, Terauchi Y.	Shirakawa J	Diabetol Metab Syndr	12	83
3	2020	Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells	Charoensuka C, Jungtrakoon P, Chanprasert C, Tangjittipokin W, Shirakawa J, Togashi Y, Orime K, Songprakhon C, Chaichanad C, Abubakar Z, Ouying P, Sujjitjoon J, Doria A, Plengvidhya N, Yenchitsomanus P	Yenchitsomanus P	Mol Cell Endocrinol.	522	111126
4	2021	The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes	Inoue R, Nishiyama K, Li J, Miyashita D, Ono M, Terauchi Y, Shirakawa J.	Shirakawa J	Cells	10(7)	1589
5	2021	The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling	Okuyama T, Kyohara M, Terauchi Y, Shirakawa J.	Shirakawa J	Int J Mol Sci	22(13)	6817
6	2021	Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report	Hasebe M, Shirakawa J, Miyashita D, Kunishita R, Kyohara M, Okuyama T, Togashi Y, Terauchi Y.	Shirakawa J	J Med Case Rep	15(1)	390
7	2021	Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes	Shirakawa J	Shirakawa J	Diabetol Int.	12(4)	349-355
8	2021	Validity and reliability of the Japanese version of the diabetes knowledge test among in-patients with type 2 diabetes	Minami T, Shirakawa J, Hiiragi H, Yamada T, Suzuki Y, Shirabe S, Maeda H, Terauchi Y	Terauchi Y	J Diabetes Investig	13(3)	580-587
9	2021	Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study	Terui S, Akamatsu R, Arai M, Inoue R, Okuyama T, Kyohara M, Li J, Tsuno T, Miyashita D, Togashi Y, Terauchi Y, Shirakawa J.	Shirakawa J	Diabetes Ther.	12(11)	2873-2889
10	2021	Pancreatic β-cell fate in subjects with COVID-19	Shirakawa J	Shirakawa J	J Diabetes Investig	12(12)	2126-2128
11	2022	Insulin regulates arginine-stimulated insulin secretion in humans	Halperin F, Mezza T, Li P, Shirakawa J, Kulkarni RN, Goldfine AB.	Goldfine AB	Metabolism	128	155117
12	2022	Imeglimin Ameliorates β-Cell Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway	Li J, Inoue R, Togashi Y, Okuyama T, Satoh A, Kyohara M, Nishiyama K, Tsuno T, Miyashita D, Kin T, Shapiro AMJ, Chew RSE, Teo AKK, Oyadomari S, Terauchi Y, Shirakawa J.	Shirakawa J	Diabetes	71(3)	424-439
13	2022	Recent developments in Phos-tag electrophoresis for the analysis of phosphoproteins in proteomics	Hirano H, Shirakawa J	Shirakawa J	Expert Rev Proteomics.	22	12